This product GTTS-WQ8442MR is a type of mRNA modified with N1-Methylpseudo-UTP, which ecodes the monoclonal antibody that targets TLR3 Agonist. The antibody can be applied in Cervical dysplasia vaccine research.
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-TLR3 Agonist, HspE7(Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WQ8442MR). Click the button above to contact us or submit your feedback about this product.
